PHC Holdings Corp
TSE:6523

Watchlist Manager
PHC Holdings Corp Logo
PHC Holdings Corp
TSE:6523
Watchlist
Price: 1 080 JPY 1.12% Market Closed
Market Cap: ¥136.9B

PHC Holdings Corp
Investor Relations

PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 9,374 full-time employees. The company went IPO on 2021-10-14. The firm operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 12, 2026
Q3 2026 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Ms. Kyoko Deguchi
President, CEO & Chairman
No Bio Available
Kaiju Yamaguchi
Executive Corporate Officer & CFO
No Bio Available
Mr. Koichiro Sato
Senior EVP, Chief Strategy Officer, COO & Representative Director
No Bio Available
Ryuichi Hirashima
Sr. Exec Corporate Officer, Chief Admin. Officer, Chief HR Officer & Chief Transformation Officer
No Bio Available
Robert Schumm
Corporate Officer & Head of BGM Division
No Bio Available
Nobuaki Nakamura
Executive Corporate Officer and Head of Diagnostics & Life Sciences Domain
No Bio Available
Kenichi Uchino
Corporate Officer
No Bio Available

Contacts

Address
TOKYO-TO
Minato-ku
2-38-5, Nishishimbashi
Contacts
+81354087280
www.phchd.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett